Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Sanofi S.A.

Start price
Target price
Perf. (%)
€85.99
17.04.21
€98.00
17.04.22
19.71%
18.04.22

buy
Bayer AG

Start price
Target price
Perf. (%)
€53.41
22.03.21
€58.00
22.03.22
11.35%
23.03.22

buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€29.88
21.03.21
€35.00
21.03.22
64.07%
22.03.22

buy
AbbVie Inc.

Start price
Target price
Perf. (%)
€115.90
16.12.21
€120.00
16.03.22
23.37%
16.03.22

buy
AstraZeneca plc

Start price
Target price
Perf. (%)
€83.63
10.03.21
€62.35
10.03.22
28.85%
10.03.22

buy
AstraZeneca plc

Start price
Target price
Perf. (%)
€79.50
02.03.21
€100.00
02.03.22
41.13%
03.03.22

buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€463.95
25.01.21
€500.00
25.01.22
15.42%
26.01.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€132.40
14.01.21
€144.00
14.01.22
10.89%
15.01.22

buy
Zoetis Inc. A

Start price
Target price
Perf. (%)
€137.00
03.01.21
€150.00
03.01.22
50.37%
04.01.22

buy
Johnson & Johnson

Start price
Target price
Perf. (%)
€125.32
28.12.20
€140.00
28.12.21
20.17%
29.12.21

Biogen Inc.

Start price
Target price
Perf. (%)
€243.10
18.10.21
€210.00
02.01.23
-12.53%
16.12.21

Could be worthwhile Investment >10% per year
Bayer AG

Start price
Target price
Perf. (%)
€47.84
12.10.21
€45.00
12.10.22
-8.10%
06.12.21

Could be worthwhile Investment >10% per year
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€442.80
23.11.20
€555.00
23.11.21
29.97%
24.11.21

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Standard Investments for future growth
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€529.00
22.11.20
€500.00
22.11.21
7.75%
23.11.21

buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€31.30
21.11.20
€40.00
21.11.21
45.99%
22.11.21

buy
Roche Holding AG ADR

Start price
Target price
Perf. (%)
€37.14
30.08.20
€41.00
04.11.21
20.64%
05.11.21

buy
Astrazeneca ADR

Start price
Target price
Perf. (%)
€47.60
30.08.20
€52.00
04.11.21
16.39%
05.11.21

buy
Abbott Laboratories

Start price
Target price
Perf. (%)
€85.41
21.08.20
€110.00
04.11.21
31.07%
05.11.21

buy
Roche Holding AG ADR

Start price
Target price
Perf. (%)
€36.51
07.08.20
€40.00
04.11.21
22.72%
05.11.21

buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€131.66
06.06.20
€205.00
04.11.21
77.81%
05.11.21

Could be worthwhile Investment >10% per year
buy
Novo Nordisk A/S

Start price
Target price
Perf. (%)
€56.30
06.06.20
€60.00
04.11.21
78.29%
05.11.21

buy
Novo Nordisk A/S

Start price
Target price
Perf. (%)
€58.96
20.04.20
€90.00
04.11.21
70.25%
05.11.21

buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€141.50
16.04.20
€175.00
04.11.21
65.44%
05.11.21

buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€27.04
17.03.20
€33.21
04.11.21
47.75%
05.11.21

Could be worthwhile Investment >10% per year
buy
Alexion Pharmaceutical Inc.

Start price
Target price
Perf. (%)
€70.50
12.03.20
€145.00
04.11.21
119.55%
05.11.21

Could be worthwhile Investment >10% per year